Respivert Ltd clinical trials
Acquired by Johnson & Johnson, 2010 · source ↗
The registry lists 11 studies whose lead sponsor is Respivert Ltd. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 4, 2016.
Before and after it joined Johnson & Johnson
- First submitted before Respivert Ltd became part of Johnson & Johnson
- 0
- First submitted after Respivert Ltd became part of Johnson & Johnson
- 9
- Unclear, or no submission date
- 2
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Respivert Ltd11 studies
Something wrong with this grouping? Tell us on the Johnson & Johnson page.
Studies
Recruiting first, then most recently updated. Showing 11 of 11. All Johnson & Johnson studies →
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of RV6153TerminatedNCT02517359Phase 1
Sponsor listed in the registry: Respivert Ltd · First submitted after Respivert Ltd became part of Johnson & Johnson
- Biomarker Assay Validation in Healthy Smokers and COPD Smokers and Ex-smokersCompletedNCT02490358
Sponsor listed in the registry: Respivert Ltd · First submitted after Respivert Ltd became part of Johnson & Johnson
- A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Repeat Doses of RV1729 for 28 Days in Patients With COPDCompletedNCT02140346Phase 1
Sponsor listed in the registry: Respivert Ltd · First submitted after Respivert Ltd became part of Johnson & Johnson
- A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of RV1729 for up to 28 DaysCompletedNCT02140320Phase 1
Sponsor listed in the registry: Respivert Ltd · First submitted after Respivert Ltd became part of Johnson & Johnson
- Safety, Tolerability and Pharmacokinetics (PK) of RV1162 in Healthy Subjects and COPD PatientsCompletedNCT01970618Phase 1
Sponsor listed in the registry: Respivert Ltd · First submitted after Respivert Ltd became part of Johnson & Johnson
- A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of RV1729CompletedNCT01813084Phase 1
Sponsor listed in the registry: Respivert Ltd · First submitted after Respivert Ltd became part of Johnson & Johnson
- A Study to Investigate the Safety and Tolerability of a New Inhaled Formulation of RV568 in Healthy VolunteersCompletedNCT01661244Phase 1
Sponsor listed in the registry: Respivert Ltd · First submitted after Respivert Ltd became part of Johnson & Johnson
- Sample Collection in Smoking AsthmaCompletedNCT01676467
Sponsor listed in the registry: Respivert Ltd · First submitted after Respivert Ltd became part of Johnson & Johnson
- A Study to Investigate How Safe and Well Tolerated RV568 is in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01475292Phase 2
Sponsor listed in the registry: Respivert Ltd · First submitted after Respivert Ltd became part of Johnson & Johnson
- RV568 - Viral Challenge With RSVCompletedNCT01230645Phase 1
Sponsor listed in the registry: Respivert Ltd · Unclear whether first submitted before or after Respivert Ltd became part of Johnson & Johnson
- Vienna Challenge Chamber Study Using RV658 in Subjects With Allergic RhinitisCompletedNCT01230619Phase 2
Sponsor listed in the registry: Respivert Ltd · Unclear whether first submitted before or after Respivert Ltd became part of Johnson & Johnson